Corrs In Brief: Therapeutic Goods: A New Treatment for the Regulators

10 July 2006

---

Significant amendments to the Therapeutic Goods Act 1989 (Cth) (Act) are twofold in effect: they increase the Therapeutic Goods Administration’s (TGA) enforcement options for breach and deter non-compliance with existing requirements under the Act. The amendments are partly the result of the Pan Pharmaceuticals recall, which raised enforcement and penalty questions, these amendments follow the global trend of increased regulation of corporate governance. Partner Conway Restom and solicitor Virginia Crawter report on the implications of these new amendments.

For a full copy of this document, please download the attached PDF.

---

This article provides information about topical legal issues.
Information contained in this article is intended as an introduction only and should not be relied on in place of legal advice.